Reported 8 months ago
The ongoing COVID-19 situation has led to a surge in the purchase of fever-reducing and pain-relieving medications at pharmacies. Ponstan has initiated a price increase recently, with different variants set to rise by nine to twenty yuan per box starting July this year, marking about a five to six percent increase. This comes amid reports of shortages and the looming prospect of other drugs following suit with price hikes, affecting popular medications like artificial tears and eye drops as well. Consumers are feeling the impact as prices rise, leading to concerns over affordability and brand loyalty in the face of escalating costs and supply chain issues.
Source: YAHOO